Canopy Growth Corp
CGC · XNASCIK 1737927fmd_1KMJ5TK1Z8PEGEASJ49CYBYBSHManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Apr 01, 2016 to Sep 30, 2026, 36 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 40 | 78 | 226 | 399 | 547 | 476 | 333 | 297 | 269 | 285 |
| Cost of revenue | – | 45 | 198 | 430 | 480 | 663 | 397 | 216 | 189 | 215 |
| Net interest income | – | – | – | – | – | (10) | – | – | – | – |
| Gross profit | 39 | 33 | 28 | (32) | 67 | (187) | (64) | 81 | 80 | 70 |
| Research and development | 1 | 2 | 15 | 62 | 58 | 32 | 22 | 5 | 3 | 3 |
| Selling, general and administrative | 30 | 103 | 392 | 694 | 575 | 415 | 343 | 229 | 170 | 160 |
| Total operating expenses | – | 153 | 666 | 1,637 | 1,310 | 831 | 2,567 | 310 | 197 | 231 |
| Operating income | (14) | (120) | (637) | (1,669) | (1,243) | (1,019) | (2,631) | (229) | (117) | (162) |
| Interest expense | – | 1 | 2 | 7 | 8 | 104 | 126 | 105 | 75 | 38 |
| Other non-operating income (expense) | – | 70 | (60) | 224 | (388) | 751 | (456) | (279) | (391) | (101) |
| Income before taxes | (10) | (51) | (708) | (1,509) | (1,684) | (268) | (3,086) | (508) | (508) | (263) |
| Income tax expense | (3) | (0) | 4 | (122) | (13) | (9) | (6) | 12 | 7 | 0 |
| Net income from continuing operations | (8) | (51) | (712) | (1,387) | (1,671) | (259) | (3,080) | (520) | (515) | (263) |
| Net income | (8) | (67) | (736) | (1,321) | (1,745) | (310) | (3,278) | (694) | (509) | (263) |